免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

PubMed

医学中患者特异性三维打印的使用与监管:对医师终端用户的调查

PMID:41770469 ·

R, u, t, h, , S, h, a, y, l, o, r, ;, , Y, o, t, a, m, , L, i, o, r, ;, , J, i, l, l, i, a, n, , S, h, a, p, i, r, o, ;, , T, h, o, m, a, s, , F, e, r, r, e, t, t, o, ;, , F, r, a, n, k, , J, , R, y, b, i, c, k, i, ;, , J, a, s, a, m, i, n, e, , C, o, l, e, s, -, B, l, a, c, k

期刊3D printing in medicine
年份
PMID41770469

摘要

Technological advancements have made 3D printing more accessible and affordable for both individuals and institutions. Despite significant efforts by the International Medical Device Regulators Forum to standardize 3D printing regulations for medical use, challenges remain. We conducted a survey to gather insights from physician end-users on their opinions regarding the regulation of 3D printing in medicine. Additionally, since FDA guidance is often adopted internationally, this survey aimed to

官方来源

在 PubMed 上查看 →

数据来自 PubMed / NCBI。有关全文和最新信息,请始终参阅官方记录。

↑